Autism Impact Fund (AIF) is dedicated to investing in innovative autism services and life science breakthroughs. The fund focuses on life science advancements, therapeutics, and service companies that enhance the lives of individuals with autism spectrum disorder (ASD) and related conditions. AIF aims to create a world where diagnosis for neurodevelopmental disorders is achievable with a simple blood test, behavioral therapy is clinically validated and data-driven, and microbiome-targeted therapeutics improve nervous system function.
AIF has made significant strides by supporting companies across various stages, from seed to Series C funding. Their portfolio includes ventures that are pioneering accessible care for individuals with disabilities and advancing diagnostic and therapeutic solutions. Through strategic investments, AIF is driving impactful changes in the autism community, fostering an environment where innovative solutions can thrive and improve the quality of life for those affected by ASD.
